An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3

Condition:   Gaucher Disease, Type 3 Interventions:   Drug: Gene therapy;   Drug: Enzyme Replacement Agent Sponsor:   AVROBIO Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials